AusTrials will be having a well-deserved break from the 23rd December 2023 returning on 2nd January 2024. If you are a participant with urgent enquiries, please refer to the number on your emergency contact card or call 1300 190 841 and leave a message.
With the development of new sites across Australia, AusTrials is pleased to release an updated site capabilities document. This provides further information on AusTrials and covers important information on the facilities and capabilities of all our Brisbane, Sydney, and Melbourne sites. Our new site capabilities document can be found here.
Indigenous peoples in high income countries are disproportionately affected by Type 2 Diabetes. Socioeconomic disadvantages and inadequate access to appropriate healthcare are important contributors. This systematic review, co-authored by Associate Professor Roy Rasalam (Principal Investigator at AusTrials Sunshine in Melbourne), investigates effective designs of primary care management of Type 2 Diabetes for Indigenous adults in…
The ever-increasing number of drugs available to treat type 2 diabetes and the complexity of patients with this condition present a constant challenge when it comes to identifying the most appropriate treatment approach. The more recent glucagon-like peptide-1 receptor agonists (GLP-1RAs) are non-insulin injectable options for the management of type 2 diabetes. Effective at improving…
